Tumor size, histological subtype and grade, lymph node status and expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are routinely used for classification of BC. This evidence concerns the gene ESR1 and breast cancer.